READING, Pa., Oct. 23, 2018 /PRNewswire/ -- Research recently
published by PharmaForce International (PFI) reports key changes in
the functions of MSLs within 12 leading pharmaceutical companies in
the United States. This research
is outlined in PFI's 2018 MSL Benchmarking Study.
The majority of these companies within the report indicated that
they now require MSLs to use various platforms to track standard
information such as number of account calls per day, number of
interactions, insights collected and other key details.
In addition to standard information, some companies request
documentation of their MSLs' field interactions using a free text
format. Any face-to-face communications that lead to significant
data recorded between MSLs and Key Opinion Leaders (KOLs) can be
reviewed by strategy leads or upper management, and utilized
accordingly.
Joyce Wedemeyer, Director of
Marketing and Sales at PharmaForce International, says it gives
pharmaceutical companies a more organized approach to not only
track and compare the performance of their MSLs, but to pull
noteworthy insights from interactions with KOLs.
"Furthermore, the utilization of tracking platforms for the MSL
function can advance sharing of information throughout commercial
and medical affair areas. Essentially, it could improve the
capability of personnel within the organization to stay connected"
says Wedemeyer.
Additional MSL trends captured in this report include insight
specific to:
- Key changes in the functions of MSLs within leading
pharmaceutical companies
- Strategic approaches to the MSL function
- Consistent increase in "account-based" organizational
approaches vs traditional KOL engagement across field medical
organizations
- Commitment toward Health Economics Outcomes Research (HEOR)
field-based personnel
- Reduction in the compensation gap between "start-up biotech"
and large pharma salaries
For more information on the report mentioned above, or the
upcoming EU5 MSL release, please contact Joyce Wedemeyer at
Joyce.Wedemeyer@strategicreports.com or by phone at
610-370-2906.
PharmaForce International (PFI) is a competitive
intelligence firm with over two decades of experience in the
pharmaceutical and biotech industries. PFI has become the market
leader in commercial operations benchmarking and competitive
intelligence. The globally focused company employs market place
experts uniquely qualified to perform research required by clients
in most major pharmaceutical markets around the world.
Related Links https://www.pharmaforce.biz
View original content to download
multimedia:http://www.prnewswire.com/news-releases/pharmaforce-international-us-pharmaceutical-companies-move-toward-utilization-of-tracking-platforms-for-medical-science-liaison-deployment-300736180.html
SOURCE PharmaForce International